Combination Therapy with Renin-Angiotensin System Blockers and Vitamin D Receptor Activators for Predialysis Patients Is Associated with the Incidence of Cardiovascular Events after Dialysis Initiation: A Multicenter Nonrandomized Prospective Cohort Study

BACKGROUND: Several human studies reported that the combined use of renin-angiotensin system blockers (RASBs) and vitamin D receptor activators (VDRAs) resulted in decreased urinary protein excretion. However, it is unknown whether this combination therapy influences the incidence of cardiovascular...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Cardiorenal Med
Autors principals: Inaguma, Daijo, Ito, Eri, Koide, Shigehisa, Takahashi, Kazuo, Hayashi, Hiroki, Hasegawa, Midori, Yuzawa, Yukio
Format: Artigo
Idioma:Inglês
Publicat: S. Karger AG 2017
Matèries:
Original Paper
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5757592/
https://ncbi.nlm.nih.gov/pubmed/29344028
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1159/000479894
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars